Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Guselkumab by Johnson & Johnson for Skin Inflammation: Likelihood of Approval
Guselkumab is under clinical development by Johnson & Johnson and currently in Phase II for Skin Inflammation. According to GlobalData,...
Guselkumab by Johnson & Johnson for Crohn's Disease (Regional Enteritis): Likelihood of Approval
Guselkumab is under clinical development by Johnson & Johnson and currently in Pre-Registration for Crohn's Disease (Regional Enteritis). According to...
Guselkumab by Johnson & Johnson for Crohn's Disease (Regional Enteritis): Likelihood of Approval
Guselkumab is under clinical development by Johnson & Johnson and currently in Pre-Registration for Crohn's Disease (Regional Enteritis). According to...